cURL Error: Failed to connect to 217.15.170.3 port 80 after 1064 ms: Couldn't connect to servercURL Error: Failed to connect to 217.15.170.3 port 80 after 1041 ms: Couldn't connect to server Monitoring of GSK situation on February 07, 2025
Stocks Prognosis
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site

GSK delivers strong 2024 performance with further improvement to long-term growth outlook

Published on February 7, 2025
GSK PLC (GSK) reported a strong performance in 2024 with an improved outlook for long-term growth. The company's revenue exceeded expectations, thanks to the success of its HIV and cancer drugs. The positive results have led GSK to launch a 2 billion dollar share buyback program. Despite the challenges faced by the global vaccine market, GSK remains optimistic about its vaccine portfolio. Experts from Stocks Prognosis recommend considering buying GSK stocks for a favorable forecast of their movement.
Go to GSK Page

Investor opinions & comments

To leave a comment, you need to Login or Register.

There are no comments yet. Be the first to leave one!

Other Data for GSK

GSK delivers strong Q3 performance and upgrades 2025 guidance

November 5, 2025

QuantWave Hits the Mark: GSK PLC Price Target Forecast Achieves 13.72% Profit

October 1, 2025

QuantWave Hits Bullseye with GSK PLC Forecast, Yielding 21.25% Profit

October 1, 2025

QuantWave's Forecast Delivers 12.77% Profit as GSK PLC Hits Price Target

October 1, 2025

QuantWave Achieves Stellar 14.46% Profit Forecast for GSK PLC

October 1, 2025

QuantWave Achieves 10.45% Profit Target Forecast for GSK PLC

October 1, 2025

Related Data

No related news found.